BioLineRx Earning Date (BLRX)

USA |NASDAQ |USD |ADR

BLRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 26, 2022 (est) Mar 31, 2022 - $-0.10 $-0.02
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 26, 2022 (est) Mar 31, 2022 - $0.00 $0.00

Biolinerx's next estimated earnings date (based on same quarter last year's date) is May 26, 2022 for the fiscal quarter ending Mar 31, 2022.

BLRX Earnings Date & History Chart

BLRX Earnings & Revenue Forecast

BLRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.70 $-0.76 $-0.65

BLRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.70 $-0.70 $-0.57

BLRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $0.00 $0.00 $0.00

BLRX Earnings Date & Revenue History

BLRX Earnings History

|
Show More
Show More

BLRX Revenue History

|
Show More
Show More

Biolinerx Next Earnings Date & Report

BLRX Mar 2022 (FQ) Earnings Date & Report Preview

BLRX's next estimated earnings date (based on same quarter last year's report date) is May 26, 2022 for the fiscal quarter ending Mar 31, 2022.

Biolinerx Previous Earnings Dates & Reports

BLRX Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Biolinerx's previous earnings date was Mar 16, 2022 for its fiscal quarter ended Dec 31, 2021.

BLRX's earnings per share (EPS) was $-0.10, beating the consensus analysts forecast of $-0.14 by 28.57%.

The EPS was higher than the previous fiscal quarter (Sep 2021) by -33.33%, and higher than the same period a year before (Dec 2020) by -83.33%.

Revenues were $0.00.

The company reported a net income of $-4.30M.

Free cash flow for the quarter was $-5.57M , compared to $-5.01M last quarter and $-5.43M a year before.

BLRX ended the quarter with $4.65M in total debt, a decrease of -14.22% compared to the previous quarter, and a decrease of -22.78% compared to the same quarter a year before.

BLRX Previous Earnings Date & Report Recap: Dec 2021 (FY)

Biolinerx's previous annual earnings date was Mar 16, 2022 for its fiscal year ended Dec 31, 2021.

BLRX's earnings per share (EPS) was $-0.42, beating the consensus analysts forecast of $-0.70 by -40.00% , and higher than the previous year's EPS (Dec 2020) by -78.46%.

Revenues were $0.00.

The company reported a net income of $-27.05M.

Biolinerx reported a free cash flow of $-23.67M for its fiscal year, compared to $-23.21M a year ago.

The company ended the fiscal year with $4.65M in total debt, a decrease of -22.78% compared to the previous year.